BridgeMD
New treatment option for Brain Tumor, Primary
Official title FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients
ClinicalTrials.gov ID: NCT06282562
What this study is testing
- What it's testing
- The FeelFit study aims to assess the effectiveness of High-Intensity Interval Training (HIIT) in improving self-reported physical fitness in adult brain tumor patients during periods of stable disease, as compared to a waiting-list control group. Furthermore, several secondary and exploratory outcomes will be evaluated.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- reduced self-reported physical fitness;
- minimum age of 18 years;
- diagnosed with a primary brain tumor;
- stable disease, i.e. no signs of radiological or clinical tumor progression;
- no oncological treatment for at least two months prior to inclusion;
You likely can't join if
- Karnofsky Performance Score \< 70;
- already participated in a HIIT program \< 1 month prior;
- contraindication of exercise.
See the full eligibility criteria
- reduced self-reported physical fitness;
- minimum age of 18 years;
- diagnosed with a primary brain tumor;
- stable disease, i.e. no signs of radiological or clinical tumor progression;
- no oncological treatment for at least two months prior to inclusion;
- able to speak, read and write in Dutch.
- Karnofsky Performance Score \< 70;
- already participated in a HIIT program \< 1 month prior;
- contraindication of exercise.
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.